2022-003460-24Ongoing
Pilot study to determine the intraTUMORal OsImertinib concentration in patients with peritoneal metastasizeD colorectal cancer (TUMOROID study)
Radboud University Medical CenterEU Clinical Trials Register
VerifiedEU Clinical Trials Register
Study focus
- Disease/Condition
- Colorectal cancer
Sponsor & location
- Primary sponsor
- Radboud University Medical Center
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
• Not fit to undergo surgery
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-003460-24
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-003460-24 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud University Medical Center and is currently Ongoing. The study focuses on Colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.